208 related articles for article (PubMed ID: 24121817)
1. Role of focal salvage ablative therapy in localised radiorecurrent prostate cancer.
Kanthabalan A; Arya M; Punwani S; Freeman A; Haroon A; Bomanji J; Emberton M; Ahmed HU
World J Urol; 2013 Dec; 31(6):1361-8. PubMed ID: 24121817
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER).
Valle LF; Lehrer EJ; Markovic D; Elashoff D; Levin-Epstein R; Karnes RJ; Reiter RE; Rettig M; Calais J; Nickols NG; Dess RT; Spratt DE; Steinberg ML; Nguyen PL; Davis BJ; Zaorsky NG; Kishan AU
Eur Urol; 2021 Sep; 80(3):280-292. PubMed ID: 33309278
[TBL] [Abstract][Full Text] [Related]
3. Salvage Therapy Options for Local Prostate Cancer Recurrence After Primary Radiotherapy: a Literature Review.
Golbari NM; Katz AE
Curr Urol Rep; 2017 Aug; 18(8):63. PubMed ID: 28688020
[TBL] [Abstract][Full Text] [Related]
4. Cancer control and complications of salvage local therapy after failure of radiotherapy for prostate cancer: a systematic review.
Parekh A; Graham PL; Nguyen PL
Semin Radiat Oncol; 2013 Jul; 23(3):222-34. PubMed ID: 23763889
[TBL] [Abstract][Full Text] [Related]
5. Salvage treatment for radio-recurrent prostate cancer: a review of literature with focus on recent advancements in image-guided focal salvage therapies.
Haj-Hamed M; Karivedu V; Sidana A
Int Urol Nephrol; 2019 Jul; 51(7):1101-1106. PubMed ID: 30977019
[TBL] [Abstract][Full Text] [Related]
6. Intraprostatic Cancer Recurrence following Radical Radiotherapy on Transperineal Template Mapping Biopsy: Implications for Focal Ablative Salvage Therapy.
Kanthabalan A; Arya M; Freeman A; Mitra AV; Payne H; Peters M; Shah TT; Emberton M; Ahmed HU
J Urol; 2020 Nov; 204(5):950-955. PubMed ID: 32602770
[TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness Analyses of Salvage Prostatectomy and Salvage Radiotherapy Outcomes Following Focal or Whole-Gland Ablative Therapy (High-Intensity Focused Ultrasound, Cryotherapy or Electroporation) for Localised Prostate Cancer.
Nathan A; Ng A; Mitra A; Sooriakumaran P; Davda R; Patel S; Fricker M; Kelly J; Shaw G; Rajan P; Sridhar A; Nathan S; Payne H
Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):e69-e78. PubMed ID: 34740477
[TBL] [Abstract][Full Text] [Related]
8. Locally ablative therapies for primary radiation failures: a review and critical assessment of the efficacy.
Huang WC; Lee CL; Eastham JA
Curr Urol Rep; 2007 May; 8(3):217-23. PubMed ID: 17459271
[TBL] [Abstract][Full Text] [Related]
9. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy.
Kimura M; Mouraviev V; Tsivian M; Mayes JM; Satoh T; Polascik TJ
BJU Int; 2010 Jan; 105(2):191-201. PubMed ID: 19583717
[TBL] [Abstract][Full Text] [Related]
10. Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer.
Chesnut GT; Tin AL; Sivaraman A; Takeda T; Lee T; Fainberg J; Benfante N; Sjoberg DD; Vargas HA; Fine SW; Scardino PT; Eastham JA; Coleman JA; Touijer KA; Zelefsky MJ; Ehdaie B
Urol Oncol; 2021 Aug; 39(8):495.e17-495.e24. PubMed ID: 33583697
[TBL] [Abstract][Full Text] [Related]
11. Local salvage of radiorecurrent prostate cancer.
Henderson RH; Bryant C; Nichols RC; Mendenhall WM; Mendenhall NP
Prostate; 2023 Aug; 83(11):1001-1010. PubMed ID: 37150849
[TBL] [Abstract][Full Text] [Related]
12. Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: a review.
Alongi F; De Bari B; Campostrini F; Arcangeli S; Matei DV; Lopci E; Petralia G; Bellomi M; Chiti A; Magrini SM; Scorsetti M; Orecchia R; Jereczek-Fossa BA
Crit Rev Oncol Hematol; 2013 Dec; 88(3):550-63. PubMed ID: 23953795
[TBL] [Abstract][Full Text] [Related]
13. Focal salvage therapy for local prostate cancer recurrences after primary radiotherapy: a comprehensive review.
Duijzentkunst DA; Peters M; van der Voort van Zyp JR; Moerland MA; van Vulpen M
World J Urol; 2016 Nov; 34(11):1521-1531. PubMed ID: 27012712
[TBL] [Abstract][Full Text] [Related]
14. Brachytherapy for the treatment of recurrent prostate cancer after radiotherapy or radical prostatectomy.
Gomez-Veiga F; Mariño A; Alvarez L; Rodriguez I; Fernandez C; Pertega S; Candal A
BJU Int; 2012 Feb; 109 Suppl 1():17-21. PubMed ID: 22239225
[TBL] [Abstract][Full Text] [Related]
15. Salvage of locally recurrent prostate cancer after definitive radiotherapy.
Mendenhall WM; Henderson RH; Hoppe BS; Nichols RC; Mendenhall NP
Am J Clin Oncol; 2014 Aug; 37(4):411-6. PubMed ID: 22772432
[TBL] [Abstract][Full Text] [Related]
16. [Salvage cryotherapy for recurrent prostate cancer after radiotherapy failure: principles, indications, patient selection, oncological results and morbidity].
Hétet JF; Colls P; Pocholle P; Chauveau P; Barré C; Hallouin P
Cancer Radiother; 2014 Nov; 18(7):701-8. PubMed ID: 24910288
[TBL] [Abstract][Full Text] [Related]
17. [Salvage treatments for prostatic radiation failure].
Baumert H
Cancer Radiother; 2010 Oct; 14(6-7):442-5. PubMed ID: 20801701
[TBL] [Abstract][Full Text] [Related]
18. Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation.
Ramsay CR; Adewuyi TE; Gray J; Hislop J; Shirley MD; Jayakody S; MacLennan G; Fraser C; MacLennan S; Brazzelli M; N'Dow J; Pickard R; Robertson C; Rothnie K; Rushton SP; Vale L; Lam TB
Health Technol Assess; 2015 Jul; 19(49):1-490. PubMed ID: 26140518
[TBL] [Abstract][Full Text] [Related]
19. [Salvage HIFU after radiotherapy and salvage radiotherapy after HIFU in locally recurrent prostate cancer: Retrospective analysis of morbidity].
Lee JW; Chevallier D; Gal J; Rouscoff Y; Natale R; Chand ME; Raffaelli C; Ambrosetti D; Durand M; Amiel J; Hannoun-Levi JM
Prog Urol; 2014 Dec; 24(16):1076-85. PubMed ID: 25241245
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of two ablation techniques for treatment of radio-recurrent prostate cancer.
Nair SM; Peters M; Kurver P; Lavi A; Verhoeff JJC; van der Voort van Zyp JRN; van Son MJ; Chin JL
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):186-192. PubMed ID: 32814843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
